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Proteins mapping at different loci are involved in melano-
genesis and share several characteristic structural features (b 
locus, c locus, and slaty locus products). We describe a method 
to produce specific antibodies against human tyrosinase, the 
product of the c locus. Mouse L cells transfected with a 
human tyrosinase cDNA were used to generate antibodies by 
immunization of syngeneic C3H mice. These antibodies 
were able to precipitate the tyrosinase glycoprotein from 
both melanocytic cells and transfectants expressing tyrosin-
ase. In contrast, transfectants expressing the related but dis-
tinct b locus protein (gp75 or TRP-l) did not react with these 
A number of genes have been implicated in the regula-tion of pigmentation in mammals [1]. The best char-acterized of these genes, located at the c locus, encodes tyrosinase (EC 1.14.18.1) [2]. Tyrosinase is a mem-brane glycoprotein that is specifically expressed in 
melanocytes. A related glycoprotein, gp75 (the product of the b 
locus, also called TRP-1), is also specifically expressed by cells of the 
melanocytic lineage and is localized to melanosomal membranes 
[3]. Recently, other potential members of this family have been 
identified, designated TRP-2 and Pmel 17 [4,5]. Tyrosinase, gp75 
(or TRP-1), and TRP-2 display a number of structural similarities. 
These three gene products: 1) are homologous (between 40% and 
45% at the amino acid level) but distinct from one another; 2) have 
nearly identical molecular masses; 3) have highly conserved cys-
teine residues that are implicated in tertiary structure; 4) include 
putative copper binding sites that could be involved in enzymatic 
activities; and 5) contain transmembrane domains at comparable 
positions. These observations have led to the concept of a broader 
"tyrosinase-related" family of proteins [6]. Antibodies have played a 
crucial role in identifying and characterizing these genes and their 
products. Most of these antibodies were derived before the family of 
tyrosinase-related proteins was identified. Antibodies against mela-
nocyte antigens have been generated by immunizing animals with 
whole cells (most frequently melanoma cells), purified proteins, or 
peptides. Based on the similarities of these proteins, antibodies 
against one member of the tyrosinase-related protein family fre-
quently react with other distinct family members. As a result, speci-
ficities of antibodies against tyrosinase, TRP-1, and other members 
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antibodies. In most cases, tyrosinase enzymatic activity could 
be precipitated and recovered in immune complexes, but one 
antibody response blocked tyrosinase activity. Immunostain-
ing with anti-tyrosinase antibodies revealed an intracellular 
granular pattern in tyrosinase transfectants and melanocytic 
cells, but not transfectants expressing the b locus protein. 
This approach provides a general method to produce specific 
antibodies against tyrosinase, other members of the tyrosin-
ase family of proteins, and potentially any other differentia-
tion antigen. Key words: pigl11entatioll/tral1sjectants/l11elanit/. 
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have often remained incompletely defined . For instance, antibodies 
against tyrosinase were used to isolate the mouse TRP-1 gene, the 
mouse TRP-2 gene, and the human Pmel17 gene [4- 7]. The isola-
tion of genes that encode these proteins has permitted the genera-
tion of polyclonal antisera against defined peptide sequences that are 
distinct for each protein member of the tyrosinase family [8]. This 
approach has provided valuable reagents. For instance, recently the 
product of the TRP-2 gene has been identified by raising antisera 
against synthetic peptides corresponding to unique sequences of 
TRP-2 [4]. Transfected cell lines expressing these different gene 
products provide another way to generate potentially unambiguous 
reagents. In this report, we describe the use of mouse fibroblasts 
transfected with human tyrosinase cDNA to generate antibodies 
against tyrosinase that do not cross-react with TRP-1 by immuniza-
tion of syngeneic C3H mice. We have characterized the specificity 
of antibodies produced by this method against cells of the melano-
cytic lineage and non-melanocytic cells expressing human tyrosin-
ase and gp75/TRP-1. 
MATERIALS AND METHODS 
Cells and Cell Lines Human melanoma cell lines (SK-MEL-30, SK-
MEL-188, SK-MEL-204, clone 1-5 ofSK-MEL-131 , and clone 22 ofSK-
MEL-23) and the human melanocyte culture FS120 were cultured as previ-
ously described [9]. The human renal cell carcinoma SK-RC-28 [10] and the 
mouse melanoma cell line B 16 [11] have been reported. L-TY cells are 
mouse fibroblast L cells stably transfected with the human tyrosinase cDNA 
BB-TY1, and cultured as described [12]. L-GP cells were generated in a 
similar manner by transfection of a full-length cDNA encoding gp75 
(TRP-1) into L cells (S. Vijayasaradhi el ai, manuscript in preparation). All 
cell lines were grown in modified Eagle's medium (MEM) supplemented 
with 10% fetal bovine serum (FBS) and non-essential amino acids, antibiot-
ics, and L-glutamine. 
Antibodies The monoclonal antibody (MoAb) TA99, directed against 
gp75 (TRP-1), has been reported elsewhere [13]. Polyclonal rabbit serum 
raised against purified murine tyrosinase was a generous gift from Dr. B. B. 
Fuller, University of Oklahoma [14]. Rabbit anti-mouse immunoglobulin 
(Ig) conjugated to peroxidase for enzyme-linked immunoassay (ELISA) 
screenings was from Sigma Chemical Co. (St. Louis, MO). Unlabeled and 
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Table I. Characterization of Sera from Mice Immunized with Transfectants Expressing Human Tyrosinase 
Method 
Immunoprecipitation of 
a 70 - 75-kOa band' 















M4 M5 M6 M7 M8 
+ + 
NO NO + 
+ + 
• M 1 to M8 are sera from eight different mice, each of which received four immunizations with L-TV transfectant cells as described in Materials alld Methods. 
• Immunoprecipitation was from "S-methionine -labeled L-TV transfectants or human melanoma cell lines. 
, Assay by ill situ melanin formatioll. 
J ND, not done. 
, Assay by ELISA and indirect itntnunofluorescence. 
fluorescein-conjugated rabbit anti-mouse or goat anti-rabbit Ig were pur-
chased from Cappel Organon Technika Co. (Westchester, PAl. 
Generation and Absorption of Anti-Tyrosinase Sera Six-week-old 
female C3H mice were initially injected intraperitoneally (ip) with 5 X 106 
L-TY cells mixed in complete Freund's adjuvant followed by a second 
immunization with L-TY cells in incomplete Freund's adjuvant 2 weeks 













1 2 3 
formed using 5 X 106 L-TY cells lysed in NP-40 (at 107/ml) detergent 
buffer (150 mM NaCI, 10 mM Tris pH 7.6, 2 mm ethylenediamine tetra-
acetic acid [EOTA], 1% NP-40) and mixed with equal volumes of inc om-
plete Freund's adjuvant. Three days after the fourth immunization, mice 
were bled and sera were analyzed by ELISA (see below). Sera were obtained 
from sero-positive mice. In some instances, sera were absorbed with non-
transfected L cells to remove non-specific reactivity against L-cell compo-
nents. For these absorptions, a cell lysate of 30 X 106 L cells in phosphate-
buffered saline (PBS) containing 1% (v/v) NP40 was prepared. PBS con-
taining bovine serum albumin 1 % (w/v) was used to block strips of nitrocel-
lulose (5 mm X 100 mm) for 1 h. These membranes were then incubated 
with L cell extracts for 1 h at room temperature. Immune sera (0.5 ml) were 
then absorbed on the membranes for 1 h before use at indicated di lutions. 




1 2 1 2 3 4 
B 
Figure 1. A) Specificity of anti-tyrosinase sera. Immunoprecipitation with M3 serum of cclllysates from L cells, L-TY cells, or pigmented SK-MEL-188 
melanoma cells labeled with 35S-methionine. Lysates were immunoprecipitared with preimmune sera (Iancs 1), allli-tyrosillase M3 illllll,,,,e sera (lanes 2), or 
MoAb TA99 against gp75 (lane 3). Molecular weight markers are indicated in kOa. B) Anti-tyrosinase sera do not recognize the browII protein. Immunopre-
cipitations of cclllysates from L cells or L-GP cells (transfected with gp75 cONAl, labeled with 35S-methionine. Lysates were inununoprecipitated with 
preimmune sera (Ialles 1), control rabbit anti-tyrosinase serum (Ia lles 2), M3 anti-tyrosinase immune sera (IOI,e 3), or MoAb TA99 against gp75 (Ialle 4) . 
Molecular weight markers are indicated in kOa. 
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Itnmunofluorescence Assays Cultured cells (104) were grown on Lab-
tek 8 glass tissue culture chamber slides (Nunc, Inc., Napervi lle, IL) over-
night in a humidified incubator at 37"C. Cells were fixed with 2% parafor-
mal de hyde for 10 min at room temperature and permeabilized with 
methanol for 2 min at - 20"C. Non-specific binding was blocked by incu-
bating the slides with PBS containing 2% gamma globulin-free (GG-free) 
FBS for 1 h at room temperature. Test sera were added to the wells at the 
indicated dilutions and incubated for 1 h. The wells were washed 3 times 
with PBS containing 2% GG-free FBS and incubated with fluorescein iso-
thiocyanate (FITC)-conjugated rabbit anti-mouse Ig (1 : 100) or FITC-con-
jugated rat anti-rabbit (1 : 50) Ig as applicable. Slides were washed twice in 
PBS containing 2% GG-free serum and mounted in PBS-glycerol contain-
ingp-phenylenediamine (Sigma). The cells were viewed and photographed 
with a Nikon Optiphot microscope. 
Metabolic Labeling and Immunoprecipitations Cells (5 X 106) were 
preincubated for 3 h at 37"C in methionine-free medium with 2% dialyzed 
FBS. The cells were then metabolically labeled for approximately 18 h with 
200 IlCi 3sS-methionine (specific activity 1140 Ci/mmol with a concentra-
tion of 7.9 mCi/ml) (New England Nuclear, Boston, MA) in 3 ml of the 
same medium in 25-cm2 flasks. Cells were trypsinized and washed three 
times with icc-cold PBS prior to solubilization (at 107/ ml) in 150 mM NaCI, 
10 mM Tris, pH 7.6,1 % NP-40, 2 mM EDTA for 30 min on ice. Insoluble 
material was removed by centrifugation at 10,000 X g for 10 min. Radioac-
tive counts that were precipitated with trichloroacetic acid (5 X 106) were 
used for each immunoprecipitation. After preclearing twice with Staphylo-
coccus aI/reus (Staph A),lysates were incubated for 30 min with 3111 of primary 
a ntibody at 4" C. Immune complexes were recovered on 30 III protein A-
bound agarose beads (Pharmacia, Piscataway, NJ) , and were extensively 
washed in 1 X TNEN (Tris 10 tuM, NaCI 15 mM, EDTA 5mM, 1% 
NP-40). Samples were eluted and reduced in Laemmli buffer [15] and ana-
lyzed on 10% sodium dodecyl sulfate (SDS)-polyacrylamide gels. Radioac-
tive bands were revealed by fluorography. 
Tyrosinase Activity Assays Cell extracts were homogenized in PBS-l % 
Triton X-I00 (TXI00) and centrifuged at 4"C to remove insoluble mate-
rial. Protein concentrations were determined by Bradford's method using a 
commercial kit (BioRad, Richmond, CAl. Tyrosinase activity was assayed in 
the extracts by the method of Pomerantz, with slight modifications as previ-
ously reported [1 2] using 3H-tyrosine [16]. Alternatively, tyrosinase activity 
was recovered after immunoprecipitation and evaluated in pellets: 30 Ilg 
unlabeled total protein was incubated with various amounts of antibody 
(5- 50 Ill) in a final volume of 300 ttl for 1 h at 37 "C. The immune com-
plexes were collected by addition of 15 III of a suspension of Staph A cells 
(50% w/v in PBS-TX100) and incubation at 37"C for 30 min. The immun-
oprecipitates were centrifuged and washed three times with PBS-TXI00. 
After addition of 0.2% (w/v) L-dihydroxyphenylalanine (L-DOPA) in 
phosphate buffer, the reactions were incubated at 37"C for an additional 30 
min. Melanin formation was visualized and photographed after centrifu ga-
tion of pellets. Additional competition assays were performed as fo llows: 
whole celllysates (30 tlg of total protein) were incubated with 50 ml of a test 
serum. Increasing amounts of (5 - 50 Ill) of a second test serum were added to 
the reaction in a final volume of 300 Ill. The assay was tben executed as 
described above. 
RESULTS 
Human Tyrosinase Expressed in Mouse Fibroblasts is Immu-
nogenic when Injected into Syngeneic Mice We investigated 
whether specific antibodies against human tyrosinase could be pro-
duced using transfected cells. Eight C3H mice (H-2k haplotype) 
were immunized with syngeneic L cells (also H _2k) transfected with 
human tyrosinase cDNA (L-TY cells). Despite the substantial ho-
mology in primary amino acid sequences between mouse and 
human tyrosinase (83% ) [12], high antibody titers (> 10- 4) were 
detected against L-TY cells in sera from fOllr of eight immunized 
mice by ELISA after four immunizations (Table I) . No reactivity 
against L-TY was detected by ELISA in preimmune or normal 
mouse sera. After three immunizations (every 2 weeks over 6 
weeks), ELISA titers against L-TY ranged from 5 X 10- 3 to 
4 X 10-3, and a fourth immunization at 10 weeks boosted titers to 
> 10-4 • In all positive mice, antibodies were detected against the L 
cell parental cell line, despite their syngeneic origin, but always at a 
significantly lower titer than against L-TY cells (10- 2) . 
Sera were used to immunoprecipitate cell Iysates of the pig-
mented human melanoma cell line SK-MEL-188, the non-pig-
mented melanoma SK-MEL-131 (clone 1-5), and the tyrosinase 
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Figure 2. Anti-tyrosinase sera precipitate tyrosinase activity. SK-MEL-188 
cells or L-TY cells were lysed in 1 % NP40-PBS buffer and immunoprecipi-
tated with preimmune mouse sera (lanes 1), anti-tyrosinase M8 sera (lalles 2), 
or positive control rabbit anti-tyros inase serum (lalle 3). Immunoprecipitates 
were recovered on Staph-A cells and melanin formation was visualized after 
incubation with L-DOPA at 37 "C. A black pellet indicates ill situ melanin 
formation. 
transfectants L-TY cells. Sera from animals immunized with L-TY 
cells were capable of precipitating a single broad band of approxi-
m ate ly 70 - 80 kilodaltons (kDa) from L-TY and SK-MEL-188 cell 
Iysates (Table I; a representative immunoprecipitation using M3 
serum is s~lOwn in Fig lA). A thin band of lower mass, approxi-
mately 63 ~Da, was also detected in L-TY transfectants (probably 
representing~ intermediate product in tyrosinase biosynthesis) 
(Fig 1A). In contrast, no specific bands were precipitated from non-
transfected L cells (Fi g 1A) or from tyrosinase-negative, amelanotic 
melanoma SK-MEL-131 (clone 1-5) cells (data not shown). For 
comparison, MoAb TA99 whic h recognizes the TRP-l/gp75 gly_ 
coprotein, was used to immunoprecipitate the same panel of cell 
lysates. As expected, TA99, reacted w ith TRP-l expressed by pig-
mented human melanoma cells (Fig 1A) and wi th transfected L-GP 
cells expressing a full-length human TRP-1 cDNA (Fig 1E). MoAb 
T A99 did not react with L-TY cells and immunodepletion experi-
ments confirm ed that T A99 did not deplete the 70 - 80-kDa band 
precipitated by M3 anti-tyrosinase sera (data not shown). N one of 
the anti-tyrosinase an tibodies (M2, M3, M6, and M8) reacted with 
gp75+, tyros inase-L-GP cells by immunofluorescence assays 
(Table I) and M3 serum did not precipitate gp75/TRP-l from L-GP 
cells (Fig 1B). 
Anti-tyrosinase Antibodies Precipitate Tyrosinase Activity 
To further test tl?e specificity of immune sera, we analyzed tyrosin-
ase actIvity precipitated from cell lysates. Methods to characterize 
antibodies aga inst tyrosinase, using immunodepletion of tyrosinase 
activity, can lead to ambiguous results. For instance, we have found 
that cont:ol sera ~r monoclonal antibodies often cause up to 30% 
non-siJeclfic l~hlblt1on (a value frequently taken as positive) of en-
zymatIc actl.vl ty of tyrosinase. For this reason, we chose to analyze 
both depletion and recovery of tyros inase activity in the immune 
complexes. 
Table II. Immunoprecipitation of Tyrosine 
Hydroxylase Activity 
Precipitating Serum 
N orma! mouse serum 
Rabbit anti- tyrosinase serumb 
Mouse M3 seru m 
Mouse M6 serum 
Mouse M8 serum 
Mouse M8 serum followed 
by normal mouse serum 
Mouse M8 serum followed 
by M6 serum 
Tyrosine Hydroxylase Activity 

















• Assayed using the method of Pomerantz [16). Experiments were perfonned three 
times and gave similar results. D:lC3 arc from one experiment. 
• Kindly provided by B. Fuller [14). 
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Figure J. Immunoreactivity of anti-
tyrosinase sera against L-cell transfee-
tants. Immunostaining of L cells (A), 
or L cells transfected with eDNA en-
coding human tyrosinase, using the 
anti-tyrosinase serum M3 (dilution 
1/1000), and revealed with rabbit 
anti-mouse FITC second antibody. 
Exposure time for photomicrograph 
in (A) (untransfected L cells) was four 
times longer than for (B) to obtain cell 
outlines. Bar, 20 IlM. 
Celllysates ofSK-MEL-1SS, L cells, L-TY, SK-MEL-131 (clone 
1-5), or the mouse melanoma line B16 were precipitated with 5,10, 
or 25 ml of sera from immunized mice. Control immunoprecipita-
tions included lysates precipitated with MoAb TA99 or preimmune 
serum. Tyrosinase activity recovered in immunoprecipitates was 
visualized by formation of the pigment melanin after addition of 
L-DOPA substrate (for dopa oxidase activity) (Fig 2) and by tyrosine 
hydroxylase assays (Table II). No pigment was observed in immun-
oprecipitates of lysates from L cells or the amelanotic melanoma 
SK-MEL-131 (clone 1-5) (data not shown), or in immunoprecipi-
tates using preimmune serum (Fig 2) or MoAb TA99 (data not 
shown). In contrast, sera of three of four immune mice (mice M2, 
M3, and MS) were able to precipitate tyrosinase activity from SK-
MEL-1SS and L-TY cells (Fig 2). Interestingly, one serum (from 
mouse M6), although capable of precipitating a 70 - SO-kDa protein 
and depleting tyrosinase activity from supernatants (Tables I and II), 
failed to precipitate any detectable tyrosinase activity in either dopa 
oxidase or tyrosine hydroxylase assays (Table II and Fig 2). 
We postulated that M6 serum might alter or interfere with the 
catalytic site of tyrosinase. To test this hypothesis, MS serum was 
used to immunoprecipitate tyrosinase from L-TY cell lysates and 
then incubated with either M6 serum or control serum (Table II). 
MS serum completely depleted tyrosinase activity from celllysates 
and activity could be completely recovered in the inununoprecipi-
tate. However, addition of M6 serum to MS immunoprecipitates 
inhibited most tyrosine hydroxylase activity (Table II) and abro-
gated dopa oxidase activity (not shown). The results indicated that 
M6 serum could deplete tyrosinase activity without recovery of 
enzymatic activity in precipitates, and that M6 could inhibit tyro-
sinase activity precipitated by MS serum. Thus, M6 antibodies 
reacted with the tyrosinase molecule but inhibited tyrosine hydrox-
ylase activity and the catalytic formation of pigment, confirming 
the postulate that M6 serum contained antibodies that reacted with 
Table III. Antibody Specificities· 
Anti-tyrosinase 
Cell Line Serum MoAb TA99 Cell Description 
L cells Mouse fibroblasts 
L-GP + L cells transfected 
with gp7S cDNA 
L-TY + L cells transfected 
with tyrosinase 
cDNA 
SK-MEL-23 + + Pigmented melanoma 
SK-MEL-188 + + Pigmented melanoma 
SK-MEL-30 + + Pigmented melanoma 
SK-MEL-131 Amclanotic melanoma 
SK-MEL-204 Amelanotic melanoma 
SK-RC-28 Renal ce ll carcinoma 
FS 120 + + Normal foreskin 
melanocytes 
• Cells were stained by indirect immunofluorescence as described in Materials and 
Methods. +, granular cytoplasmic staining; -, no staining. 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
or induced conformational changes in an active catalytic site of 
tyrosinase . 
Ilnmunostaining with Anti-Tyrosinase Antibodies When 
absorbed anti-tyrosinase sera were used at a dilution of 1/1000, 
strong intracellular staining was visible on fixed and permeabilized 
tyrosinase-transfected L cells and pigmented melanoma cells but not 
parental L cells. Staining was localized to perinuclear and cyto-
plasmic granules in L-TY cells (staining with M3 serum is shown in 
Fig 3). Table III presents the results of specificity testing against a 
panel of cell lines. Two non-pigmented melanoma cell lines, SK-
MEL-131 and SK-MEL-204, and a renal cell carcinoma cell line 
SK-RC-2S, that expressed no tyrosinase activity and no tyrosinas~ 
mRNA by Northern blots (data not shown), did not react with 
antibodies. In contrast, three pigmented melanoma cell lines and 
cultured melanocytes, which were known to express high levels of 
tyrosinase .activity and ~e~e deeply pigmented, displayed intense 
cytoplasmiC granular stal11l11g (Table III and Fig 4B showing SK-
MEL-23). 
Staining with a.nti-tyrosina~e sera was compared with staining of 
Mo~b ~ A99 agamst TRP-l ~ the panel of cell lines (Table III). 
SpeCifiCity was confirmed usmg L cells transfected with a full-
le~gth ~DNA enc~ding human TRP-l. L cells expressing TRP-l 
stamed mtensely With MoAb T A99 but did not react with antibod-
!es against ty~o.sin~se (Table III). This result supports the previous 
ImmunopreClpltatlOn data showing that anti-tyrosinase did not 
cro~s-react ~ith the homologous TRP-l glycoprotein. Antibodies 
a9all1st tyrosmase generally stained fewer cytoplasmic granules than did MoAb TA99 (see Fig 4). Tyrosinase appeared to be expressed in 
only a subset of intracellular granules that expressed TRP-l. 
DISCUSSION 
The biosynthesis of tyrosinase that we have expressed in mouse L 
cell transfectants has not been fully analyzed, partly due to the lack 
of specific antibodies against human tyrosinase. However, the data 
presented in this report, together with our previous observations, 
sh~w that the .enzyme pro~essed in the L cells is: a) enzymatically 
active [l~], b) Immunogemc, and c) capable of inducing antibodies 
that speCifically recognize and precipitate a native form of the mol-
ecule. 
The application of specific transfectants has allowed the direct 
identification and evaluation of the protein of interest. Transfec-
tants have been useful in determining the specificity of serologic 
responses of the mouse to human tyrosinase. Most antibodies did 
not inhibi.t tyr?sinase catalytic activity, but at least one mouse gen-
erated antibodies that blocked tyrosinase activity. The melanosomal 
protein gp 75 or TRP-1 is considerabl y more abundant than tyrosin-
ase [17], which might explain why antibodies initially thought to be 
against tyrosinase were actually directed against TRP-1, particularly 
:vhen whole cells were used as Immunogens. For example, in exper-
Iments uSing Single transfectants expressing the murine b locus 
cDNA, Shibahara et al recently showed that the MoAb TMH-l 
reacts only with the b protein and not with tyrosinase as originally 
postulated [1S]. Rabbit anti-hamster polyclonal antibodies gener-
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Figure 4. Immunoreactivity of 
anti-tyrosinase sera against mel-
anocytic cells. Immunostaining of 
human melanoma cell line SK-
MEL-23. Cells were stained with 
MoAb TA99 against human TRP-
1 (A) or mouse anti-tyrosinase 
sera (B) . Both anti-tyrosinase 
serum and TA99 stained cytoplas-
mic vesicles. Bar, 20 11M. 
ated by Halaban and Pomerantz [19] have been valuable reagents, 
allowing the isolation of a cDNA clone encoding human tyrosinase 
[2]. However, the same polyclonal serum also cross-reacted with 
other gene products, such as the recently described TRP-2 protein, 
as illustrated by the isolation of the partial cDNA clone SA by I. J. 
Jackson [20]. Similarly, upon initial screening of a human melano-
cyte cDNA library with the rabbit anti-hamster tyrosinase antisera, 
Kwon et at isolated the unique cDNA designated Pmel17-1, whose 
product is not yet formally identified (but may be the sillier locus 
product) [5]. The most notable series of antibodies against the tyro-
sinase family proteins has been generated by Hearing and co-
workers. Using peptides with distinct and defined sequences, they 
have generated antibodies specifically against tyrosinase, TRP-1 , 
and most recently the protein encoded by the TRP-2 gene. 
It is interesting that the amino acid sequence differences between 
mouse and human tyrosinase «20%) were sufficient to generate 
high affinity (by virtue of the ability to immunoprecipitate) and 
specific antibody responses. As pointed out by Hearing and Jimenez 
[6], tyrosinase has been relatively non-immunogenic (perhaps in 
part due to its low abundance and its conservation of sequences 
between mouse and human). However, the application ofL cells as a 
source of antigen in syngeneic mice has allowed the generation of 
antibodies against this poorly immunogenic molecule. The sera 
produced by this method should allow more detailed analysis of 
transfected cells, and help to understand the biosynthesis and cellu-
lar localization of tyrosinase in transfectants. 
Both tyrosinase and TRP-l are melanosomal transmembrane 
glycoproteins. In melanoma cells and melanocytes, the granules 
stained by anti-tyrosinase serum appeared to represent a sub-popula-
tion of granules stained by MoAb TA99. In melanocytic cells, these 
vesicles presumably represent melanosomes. In the case of L-cell 
transfectants, the nature of these vesicles remains uncertain, al-
though our previous data showed that melanin produced in trans-
fectants was packaged into membrane-bound vesicles [12]. It is rea-
sonable to assume that tyrosinase was trafficked to the same vesicle 
population that packaged melanin. The ability of transfectants to 
support the stable production of pigment remains a mystery, as does 
the identity of vesicles where pigment is synthesized. The observa-
tion that only a subset of vesicles in melanoma cells and melanocytes 
stained with the anti-tyrosinase antibodies, compared to localiza-
tion of TRP-1, could reflect a difference in half-life of the two 
proteins (10-12 h for tyrosinase versus 18-24 h for gp7S). Differ-
ences in tyrosinase activities between distinct cells could reflect rates 
of synthesis, processing, and degradation. As tyrosinase is trans-
ported through the endoplasmic reticulum or the traYIS Golgi net-
work, it is possible that an inactive form of the enzyme or a precur-
sor polypeptide might not be detected by the antibodies that we 
have produced. For instance, this could reflect differences in pro-
cessing of human tyrosinase in L cells versus human melanocytic 
cells. The existence of unambiguous antibodies will allow more 
careful analysis of the biosynthesis of tyrosinase in transfected L cells 
as well as in other cell types that are potential recipients for expres-
sion of tyrosinase. 
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